CISTRON BIOTECHNOLOGY INC has a total of 12 patent applications. Its first patent ever was published in 1985. It filed its patents most often in Australia, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are SQUAREX LLC, RENHETANG PHARMACEUTICAL CO LTD and NANOPHARMACEUTICALS LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | Canada | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | United States | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Analysing materials | |
#4 | Microorganisms | |
#5 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Dondero Richard S | 7 |
#2 | Casey Leslie S | 5 |
#3 | Galton Bruce C | 5 |
#4 | March Carl J | 2 |
#5 | Larsen Alf D | 2 |
#6 | Cerretti Douglas P | 2 |
#7 | Jandinski John | 2 |
#8 | Lisi Peter J | 2 |
#9 | Hopp Thomas P | 2 |
#10 | Cosman David J | 2 |
Publication | Filing date | Title |
---|---|---|
AU2003200723B2 | Encapsulated immunomodulators useful as vaccine adjuvants | |
AU1208499A | Encapsulated immunomodulators useful as vaccine adjuvants | |
WO9842325A2 | INHIBITION OF THE CLEAVAGE OF PRECURSOR IL-1$g(b) | |
US5474899A | Selective immunoassay for IL-1 β |